VERIGEN INC has a total of 23 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are INT GENETIC ENG, SINGH MOLECULAR MEDICINE LLC and TIZONA THERAPEUTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Finland | 1 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Unspecified technologies | |
#6 | Unspecified technologies | |
#7 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Osther Kurt B | 23 |
#2 | Kellermann Gottfried H | 9 |
#3 | Hung Chung-Ho | 7 |
#4 | Dyll Louis M | 3 |
Publication | Filing date | Title |
---|---|---|
AU3632595A | Porcine antibodies to tnf-alpha(alpha) | |
US5830476A | Active induction or passive immunization of anti-Gp48 antibodies and isolated gp48 protein | |
US5658569A | Anti-HIV-1 neutralizing antibodies | |
US5529776A | Anti-HIV-1 neutralizing antibodies | |
US5264342A | Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies | |
AU9094291A | Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies | |
US5286852A | Antibodies specific towards HIV-1 gp 48 |